TCL Archive FDA cancer therapeutics review split among three units in reorganization. October 10, 2003
TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive First TIL Results: Four Patients, All Responded, One Complete; Panel Pens Reauthorization Drive November 27, 1987